Lista de obras - Andrea Ardizzoni - Dominio Público Uruguay

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).

artículo científico publicado en 2005

A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections

artículo científico publicado en 2009

A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction.

artículo científico publicado en 2007

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

artículo científico publicado en 2014

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

artículo científico

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

artículo científico publicado en 2008

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

artículo científico publicado en 2011

Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin

artículo científico publicado en 2016

Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients

article

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

artículo científico publicado en 2007

Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer

artículo científico publicado en 2007

CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage?

artículo científico publicado en 2014

Chemotherapy in metastatic renal cell carcinoma today? A systematic review

artículo científico publicado en 2013

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

artículo científico publicado en 2007

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab

artículo científico publicado en 2018

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

artículo científico publicado en 2017

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation

artículo científico publicado en 2016

Combination of target agents: challenges and opportunities.

artículo científico publicado en 2007

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

artículo científico publicado en 2012

Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites

artículo científico publicado en 2008

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.

artículo científico publicado en 2016

Current status of second-line treatment and novel therapies for small cell lung cancer.

artículo científico publicado en 2007

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

artículo científico publicado en 2006

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

artículo científico publicado en 2011

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient.

artículo científico publicado en 2014

Differential efficacy of endodontic obturation procedures: an ex vivo study

artículo científico publicado en 2013

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

artículo científico publicado en 2015

Endometrial metastasis of lung adenocarcinoma: a case report

artículo científico publicado en 2011

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

artículo científico publicado en 2017

Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer

artículo científico publicado en 2008

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

artículo científico publicado en 2003

Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer

artículo científico

European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.

artículo científico publicado en 2003

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

artículo científico publicado en 2017

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

artículo científico publicado en 2009

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Expert opinions of the first italian consensus conference on the management of malignant pleural mesothelioma

scientific article published on February 2011

FGFR as potential target in the treatment of squamous non small cell lung cancer

artículo científico

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study.

artículo científico

Farnesylated proteins as anticancer drug targets: from laboratory to the clinic

artículo científico publicado en 2004

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

artículo científico publicado en 2009

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

artículo científico publicado en 2015

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification

artículo científico publicado en 2013

Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2002

Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients

artículo científico publicado en 2014

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2.

artículo científico publicado en 2008

Histone deacetylation inhibitors.

artículo científico publicado en 2002

Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor.

artículo científico publicado en 2016

Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells

artículo científico publicado en 2014

In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity

artículo científico publicado en 2018

Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens

article

Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations

artículo científico publicado en 2015

Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer?

artículo científico publicado en 2010

Is the door open to further investigation with antiangiogenesis in SCLC?

artículo científico publicado en 2018

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

artículo científico publicado en 2015

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

artículo científico publicado en 2014

Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma

artículo científico publicado en 2005

Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

artículo científico publicado en 2017

Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology

artículo científico publicado en 2012

Metachronous solitary metastasis to the thyroid gland from squamous cell carcinoma of the lung: a case report and literature review.

artículo científico publicado en 2017

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

artículo científico publicado en 2006

Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.

artículo científico publicado en 2013

Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

artículo científico publicado en 2010

NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins

artículo científico publicado en 2006

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

artículo científico publicado en 2013

New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes

scientific article published on 08 July 2019

Osteocyte lacunar size-lamellar thickness relationships in human secondary osteons.

artículo científico publicado en 2001

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

artículo científico

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer

artículo científico publicado en 2007

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2017

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

artículo científico publicado en 2015

Predictors of clinical response of non-small cell cancer to gefitinib

artículo científico publicado en 2004

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.

artículo científico publicado en 2009

Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?

artículo científico publicado en 2015

Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology.

artículo científico publicado en 2013

Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations

artículo científico

Serodiagnosis of infectious diseases with antigen microarrays

artículo científico publicado en 2004

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

artículo científico publicado en 2002

Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer

artículo científico publicado en 2015

Systemic adjuvant therapies in renal cell carcinoma

artículo científico publicado en 2012

The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation

artículo científico publicado en 2009

The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae.

artículo científico publicado en 2013

The mycoarray as an aid for the diagnosis of an imported case of histoplasmosis in an Italian traveler returning from Brazil

artículo científico publicado en 2013

The synthetic killer peptide KP impairs Candida albicans biofilm in vitro

artículo científico publicado en 2017

Topotecan in the treatment of recurrent small cell lung cancer: an update

artículo científico publicado en 2004

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

artículo científico publicado en 2014

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

artículo científico publicado en 2005

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report

artículo científico publicado en 2009

Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach

artículo científico publicado en 2016

Yessotoxin inhibits phagocytic activity of macrophages.

artículo científico publicado en 2009

Lista de obras de Andrea Ardizzoni

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).

A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections

A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction.

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin

Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer

CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage?

Chemotherapy in metastatic renal cell carcinoma today? A systematic review

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation

Combination of target agents: challenges and opportunities.

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.

Current status of second-line treatment and novel therapies for small cell lung cancer.

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient.

Differential efficacy of endodontic obturation procedures: an ex vivo study

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

Endometrial metastasis of lung adenocarcinoma: a case report

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer

European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Expert opinions of the first italian consensus conference on the management of malignant pleural mesothelioma

FGFR as potential target in the treatment of squamous non small cell lung cancer

Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study.

Farnesylated proteins as anticancer drug targets: from laboratory to the clinic

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification

Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2.

Histone deacetylation inhibitors.

Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor.

Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells

In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity

Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens

Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations

Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer?

Is the door open to further investigation with antiangiogenesis in SCLC?

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma

Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology

Metachronous solitary metastasis to the thyroid gland from squamous cell carcinoma of the lung: a case report and literature review.

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.

Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes

Osteocyte lacunar size-lamellar thickness relationships in human secondary osteons.

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

Predictors of clinical response of non-small cell cancer to gefitinib

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.

Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?

Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology.

Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations

Serodiagnosis of infectious diseases with antigen microarrays

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer